[CLINICAL TRIAL OF A NEW NEUROLEPTIC DRUG, DIXYRAZINE, WITH APPLICATION OF A DOUBLE-BLIND CONTROL TECHNIC AND SERIAL ANALYSIS].
D014150:Antipsychotic Agents; D035843:Biomedical Research; D002648:Child; D004311:Double-Blind Method; D004358:Drug Therapy; D006801:Humans; D006919:Hydroxyzine; D001523:Mental Disorders; D010640:Phenothiazines; D011395:Promazine
D014150:Antipsychotic Agents; D010640:Phenothiazines; D006919:Hydroxyzine; C012950:dixyrazine; D011395:Promazine
CHILD; CLINICAL RESEARCH; DRUG THERAPY; HYDROXYZINE; MENTAL DISORDERS; PROMAZINE
ESSAI CLINIQUE D'UN NOUVEL AGENT NEUROPL'EGIQUE, LA  DIXYRAZINE, AVEC APPLICATION D'UNE M'ETHODE DE CONTR OLE EN DOUBLE ANONYMAT ET DE L'ANALYSE S'EQUENTIELLE.